Lorrain Daniel S.
CIK 0001861550
Chief Scientific Officer
Filings
15
Latest Jun 1, 2026
Issuers covered
1
Showing
15 of 15
Page 1
Track record
16 of 17 open-market trades scored (94% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 16 | 63% | +1.2% | +9.2% | +22.4% | -48.0% |
| 90 days | 13 | 77% | +13.0% | +13.2% | +53.5% | -34.4% |
| 180 days | 3 | 100% | +74.0% | +72.4% | +77.2% | +72.4% |
| 365 days | 3 | 100% | +28.3% | +27.3% | +30.3% | +27.3% |
Issuers
Companies where Lorrain Daniel S. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 15 | Jun 1, 2026 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|